Phenytoin

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 51672-4069
  • Package NDC 51672-4069-2
  • Application number ANDA040521
  • SPL ID 3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26
  • SPL set ID 093fd736-5971-47af-b4ef-08c1696cebe8
  • UNII 6158TKW0C5
  • RxCUI 1313112

What the source publishes

Labeler
Sun Pharmaceutical Industries, Inc.
Active ingredients
Phenytoin
Form
SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:51672-4069_3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26
{
  "name": "Phenytoin",
  "splId": "3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26",
  "labels": [
    {
      "setId": "093fd736-5971-47af-b4ef-08c1696cebe8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=093fd736-5971-47af-b4ef-08c1696cebe8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=093fd736-5971-47af-b4ef-08c1696cebe8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Sun Pharmaceutical Industries, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (51672-4069-2)  / 237 mL in 1 BOTTLE",
      "package_ndc": "51672-4069-2",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250723"
    }
  ],
  "productId": "51672-4069_3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "51672-4069",
  "deaSchedule": null,
  "genericName": "Phenytoin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "PHENYTOIN",
      "strength": "125 mg/5mL"
    }
  ],
  "applicationNumber": "ANDA040521",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20040408",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175753",
      "N0000008486",
      "N0000191266",
      "N0000187064",
      "N0000187063",
      "N0000185607",
      "N0000191267",
      "N0000190118",
      "N0000185507"
    ],
    "upc": [
      "0351672406929"
    ],
    "unii": [
      "6158TKW0C5"
    ],
    "rxcui": [
      "1313112"
    ],
    "spl_set_id": [
      "093fd736-5971-47af-b4ef-08c1696cebe8"
    ],
    "pharm_class_pe": [
      "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
    ],
    "pharm_class_epc": [
      "Anti-epileptic Agent [EPC]"
    ],
    "pharm_class_moa": [
      "Cytochrome P450 1A2 Inducers [MoA]",
      "Cytochrome P450 2B6 Inducers [MoA]",
      "Cytochrome P450 2C8 Inducers [MoA]",
      "Cytochrome P450 2C19 Inducers [MoA]",
      "Cytochrome P450 2D6 Inducers [MoA]",
      "Cytochrome P450 3A Inducers [MoA]",
      "Cytochrome P450 2C9 Inducers [MoA]"
    ],
    "manufacturer_name": [
      "Sun Pharmaceutical Industries, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:51672-4069_3cbd8a0c-6cfb-e0dd-e063-6394a90a8a26"